Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 9 (September)

1. Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions.
   Exp Mol Pathol, 83(2): 188-97. [Abstract] [Full-text]
2. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.
   Clin Cancer Res, 13(17): 5020-7. [Abstract] [Full-text]
3. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.
   Clin Cancer Res, 13(17): 5001-9. [Abstract] [Full-text]
4. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients.
   J Natl Cancer Inst, 99(17): 1304-12. [Abstract] [Full-text]
5. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
   J Natl Cancer Inst, 99(17): 1335-9. [Abstract] [Full-text]
6. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
   Cancer Lett, 256(1): 81-9. [Abstract] [Full-text]
7. Suppression of staurosporine-mediated apoptosis in Hs578T breast cells through inhibition of neutral-sphingomyelinase by caveolin-1.
   Cancer Lett, 256(1): 64-72. [Abstract] [Full-text]
8. Pathways to tamoxifen resistance.
   Cancer Lett, 256(1): 1-24. [Abstract] [Full-text]
9. Pleomorphic ductal carcinoma of the breast with predominant micropapillary features.
   Pathol Int, 57(10): 694-7. [Abstract] [Full-text]
10. Multidisciplinary management of ductal carcinoma in situ: a 10-year experience.
    Am J Surg, 194(4): 532-4. [Abstract] [Full-text]
11. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.
    Am J Surg, 194(4): 527-31. [Abstract] [Full-text]
12. A strategic approach to the evaluation of axillary lymph nodes in breast cancer patients: analysis of 168 patients at a single institution.
    Am J Surg, 194(4): 524-6. [Abstract] [Full-text]
13. Disparities in time to definitive surgical treatment between black and white women diagnosed with ductal carcinoma in situ.
    Am J Surg, 194(4): 521-3. [Abstract] [Full-text]
14. Breast tattoos for planning surgery following neoadjuvant chemotherapy.
    Am J Surg, 194(4): 518-20. [Abstract] [Full-text]
15. Validating quality breast care: three new validation programs for 2007.
    Am J Surg, 194(4): 515-7. [Abstract] [Full-text]
16. Gradient index ductoscopy and intraductal biopsy of intraductal breast lesions.
    Am J Surg, 194(4): 511-4. [Abstract] [Full-text]
17. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
    Am J Surg, 194(4): 507-10. [Abstract] [Full-text]
18. Predicting relapse in ductal carcinoma in situ patients: an analysis of biologic markers with long-term follow-up.
    Am J Surg, 194(4): 504-6. [Abstract] [Full-text]
19. Defining social support systems for women with breast cancer.
    Am J Surg, 194(4): 501-3. [Abstract] [Full-text]
20. Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy.
    Am J Surg, 194(4): 497-500. [Abstract] [Full-text]
21. Clinical characteristics of women presenting with skin-only recurrence of breast cancer.
    Am J Surg, 194(4): 494-6. [Abstract] [Full-text]
22. Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer.
    Am J Surg, 194(4): 491-3. [Abstract] [Full-text]
23. Effective methods for disclosing breast cancer diagnosis.
    Am J Surg, 194(4): 488-90. [Abstract] [Full-text]
24. Positive impact of a breast-health triaging system on breast-care access and physician satisfaction.
    Am J Surg, 194(4): 482-7. [Abstract] [Full-text]
25. Egg retrieval with cryopreservation does not delay breast cancer treatment.
    Am J Surg, 194(4): 477-81. [Abstract] [Full-text]
26. Primary breast tumor characteristics predicting aggressive nodal involvement.
    Am J Surg, 194(4): 474-6. [Abstract] [Full-text]
27. A device for real-time, intraoperative margin assessment in breast-conservation surgery.
    Am J Surg, 194(4): 467-73. [Abstract] [Full-text]
28. The use of ductal lavage as a screening tool in women at high risk for developing breast carcinoma.
    Am J Surg, 194(4): 463-6. [Abstract] [Full-text]
29. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Am J Surg, 194(4): 456-62. [Abstract] [Full-text]
30. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast.
    Am J Surg, 194(4): 450-5. [Abstract] [Full-text]
31. Clinicopathologic features of papillary lesions on core needle biopsy of the breast predictive of malignancy.
    Am J Surg, 194(4): 444-9. [Abstract] [Full-text]
32. Scientific Presentation Award. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate breast reconstruction.
    Am J Surg, 194(4): 438-43. [Abstract] [Full-text]
33. Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors.
    Am J Surg, 194(4): 426-32. [Abstract] [Full-text]
34. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.
    Cancer, 110(6): 1201-8. [Abstract] [Full-text]
35. Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience.
    Cancer, 110(6): 1195-200. [Abstract] [Full-text]
36. Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies.
    Cancer, 110(6): 1187-94. [Abstract] [Full-text]
37. Investigate the role of PTEN in chemotaxis of human breast cancer cells.
    Cell Signal, 19(11): 2227-36. [Abstract] [Full-text]
38. MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms.
    NMR Biomed, 20(6): 602-14. [Abstract] [Full-text]
39. Genetic variation in five genes important in telomere biology and risk for breast cancer.
    Br J Cancer, 97(6): 832-6. [Abstract] [Full-text]
40. Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project.
    Br J Cancer, 97(6): 725-9. [Abstract] [Full-text]
41. Symptom-oriented follow-up of early breast cancer is not inferior to conventional control. Results of a prospective multicentre study.
    Onkologie, 30(8): 443-9. [Abstract] [Full-text]
42. Improvement of safety profile of docetaxel by weekly administration in patients with metastatic breast cancer.
    Onkologie, 30(8): 436-41. [Abstract] [Full-text]
43. Randomized controlled trial of a structured training program in breast cancer patients with tumor-related chronic fatigue.
    Onkologie, 30(8): 429-34. [Abstract] [Full-text]
44. PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas.
    Br J Cancer, 97(6): 809-17. [Abstract] [Full-text]
45. Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo.
    Br J Cancer, 97(6): 761-8. [Abstract] [Full-text]
46. Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer.
    Br J Cancer, 97(6): 802-8. [Abstract] [Full-text]
47. Cardiovascular effects of breast cancer radiotherapy.
    Cancer Treat Rev, 33(6): 578-93. [Abstract] [Full-text]
48. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors.
    Cancer Gene Ther, 14(10): 828-35. [Abstract] [Full-text]
49. Bone health in postmenopausal women with early breast cancer: how protective is tamoxifen?
    Cancer Treat Rev, 33(6): 506-13. [Abstract] [Full-text]
50. Beliefs, recommendations and intentions are important explanatory factors of mammography screening behavior among Muslim Arab women in Israel.
    Health Educ Res, 22(5): 665-76. [Abstract] [Full-text]
51. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
    Clin Genet, 72(4): 311-20. [Abstract] [Full-text]
52. Influence of IFN-gamma and its receptors in human breast cancer.
    BMC Cancer, 7: 158. [Abstract] [Full-text]
53. Comment on "The consensus coding sequences of human breast and colorectal cancers".
    Science, 317(5844): 1500. [Abstract] [Full-text]
54. Comment on "The consensus coding sequences of human breast and colorectal cancers".
    Science, 317(5844): 1500. [Abstract] [Full-text]
55. Comment on "The consensus coding sequences of human breast and colorectal cancers".
    Science, 317(5844): 1500; author reply 1500. [Abstract] [Full-text]
56. Giant cell tumor of soft tissue arising in breast.
    Ann Diagn Pathol, 11(5): 345-9. [Abstract] [Full-text]
57. Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer.
    Int J Radiat Oncol Biol Phys, 69(2): 483-9. [Abstract] [Full-text]
58. Biopsy findings after breast conservation therapy for early-stage invasive breast cancer.
    Int J Radiat Oncol Biol Phys, 69(2): 490-7. [Abstract] [Full-text]
59. The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer.
    Am J Clin Pathol, 128(4): 630-7. [Abstract] [Full-text]
60. Effects of the environmental mammary carcinogen 6-nitrochrysene on p53 and p21(Cip1) protein expression and cell cycle regulation in MCF-7 and MCF-10A cells.
    Chem Biol Interact, 170(1): 31-9. [Abstract] [Full-text]
61. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.
    Endocrinology, 148(10): 4793-802. [Abstract] [Full-text]
62. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity.
    Biochem Biophys Res Commun, 362(4): 816-21. [Abstract] [Full-text]
63. S731 in the transactivation domain modulates STAT5b activity.
    Biochem Biophys Res Commun, 362(4): 1026-30. [Abstract] [Full-text]
64. Incidence and prognosis of synchronous and metachronous bilateral breast cancer.
    J Clin Oncol, 25(27): 4210-6. [Abstract] [Full-text]
65. Sentinel lymph node biopsy for breast cancer.
    J Surg Oncol, 96(4): 322-9. [Abstract] [Full-text]
66. Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome.
    Oncogene, 26(43): 6269-79. [Abstract] [Full-text]
67. Pro-apoptotic effects of 1'-acetoxychavicol acetate in human breast carcinoma cells.
    Toxicol Lett, 173(3): 151-60. [Abstract] [Full-text]
68. Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer.
    J Surg Oncol, 96(5): 424-8. [Abstract] [Full-text]
69. Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro.
    J Pharmacol Exp Ther, 323(1): 257-64. [Abstract] [Full-text]
70. Evaluation of computer-aided detection systems in the detection of small invasive breast carcinoma.
    Radiology, 245(1): 88-94. [Abstract] [Full-text]
71. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy.
    Radiology, 245(1): 80-7. [Abstract] [Full-text]
72. Radiofrequency ablation in the management of liver metastases from breast cancer.
    AJR Am J Roentgenol, 189(4): 883-9. [Abstract] [Full-text]
73. Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts.
    AJR Am J Roentgenol, 189(4): 860-6. [Abstract] [Full-text]
74. Imaging histologic discordance at MRI-guided 9-gauge vacuum-assisted breast biopsy.
    AJR Am J Roentgenol, 189(4): 852-9. [Abstract] [Full-text]
75. Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents.
    J Control Release, 122(3): 324-30. [Abstract] [Full-text]
76. Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.
    Eur J Surg Oncol, 33(8): 972-6. [Abstract] [Full-text]
77. EGFR gene and protein expression in breast cancers.
    Eur J Surg Oncol, 33(8): 956-60. [Abstract] [Full-text]
78. Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy.
    Eur J Surg Oncol, 33(8): 977-81. [Abstract] [Full-text]
79. The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer.
    Eur J Surg Oncol, 33(8): 961-6. [Abstract] [Full-text]
80. Skin-type hidradenoma of the breast parenchyma with t(11;19) translocation: hidradenoma of the breast.
    Am J Dermatopathol, 29(5): 457-61. [Abstract] [Full-text]
81. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
    Cancer Genet Cytogenet, 178(1): 65-9. [Abstract] [Full-text]
82. Identification of rare variants in the hLIMD1 gene in breast cancer.
    Cancer Genet Cytogenet, 178(1): 36-41. [Abstract] [Full-text]
83. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis.
    Nat Rev Cancer, 7(10): 791-9. [Abstract] [Full-text]
84. Characterization of primary breast carcinomas grown in three-dimensional cultures.
    J Surg Res, 142(2): 256-62. [Abstract] [Full-text]
85. ATP modulation of mitogen activated protein kinases and intracellular Ca2+ in breast cancer (MCF-7) cells.
    Arch Biochem Biophys, 466(1): 15-23. [Abstract] [Full-text]
86. Breast cancer cell proliferation is inhibited by BAD: regulation of cyclin D1.
    J Biol Chem, 282(39): 28864-73. [Abstract] [Full-text]
87. Lobular neoplasia diagnosed at core biopsy does not mandate surgical excision.
    J Surg Res, 142(2): 275-80. [Abstract] [Full-text]
88. Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790.
    J Biol Chem, 282(39): 28328-34. [Abstract] [Full-text]
89. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women.
    Cancer, 110(7): 1578-85. [Abstract] [Full-text]
90. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.
    Cancer, 110(7): 1436-44. [Abstract] [Full-text]
91. Multifocal breast cancer in women < or =35 years old.
    Cancer, 110(7): 1445-50. [Abstract] [Full-text]
92. Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer.
    Pharmacogenomics J, 7(5): 362-5. [Abstract] [Full-text]
93. Restoring E-cadherin-mediated cell-cell adhesion increases PTEN protein level and stability in human breast carcinoma cells.
    Biochem Biophys Res Commun, 363(1): 165-70. [Abstract] [Full-text]
94. Surveillance mammography following the treatment of primary breast cancer with breast reconstruction: a systematic review.
    Plast Reconstr Surg, 120(5): 1125-32. [Abstract] [Full-text]
95. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Nat Clin Pract Oncol, 4(10): 578-90. [Abstract] [Full-text]
96. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
    Oncogene, 26(44): 6420-30. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.